+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Carrier Screening Market by Type, Technology, and End User- Global Opportunity Analysis and Industry Forecast, 2021-2030

  • ID: 5521517
  • Report
  • October 2021
  • Region: Global
  • 361 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • Eurofins Scientific
  • Fulgent Genetics Inc.
  • Illumina Inc.
  • Invitae Corporation
  • Luminex Corporation
  • Opko Health
The carrier screening market was valued at $1,378.06 million in 2020, and is projected to reach $4,002.05 million by 2030, growing at a CAGR of 11.5% from 2021 to 2030.



Genetic testing is known as carrier screening, which is performed on people who display no symptoms for a genetic disorder but may be at risk for passing it on to next generation or potentially may develop the disease later in their life. A carrier for a genetic disorder is inherited from one normal and one abnormal allele for a gene associated with the disorder. The only time people find out that they are the carrier of a specific genetic disorder is when they have an affected child. In addition, the market growth is attributed to surge in incidence of genetic diseases, increase in availability & affordability of tests, and rise in number of advanced product launches. Moreover, large biotechnology firms all over the world are increasingly focusing on acquiring companies that provide solutions for the tests, which is expected to notably contribute toward the market growth.

Furthermore, the global carrier screening market growth is largely driven by factors such as significant applications of carrier screening in genetic disorder fields, various initiatives & funding from government & private bodies for large-scale carrier screening projects, and decline in cost of screening. Prominent players in the global carrier screening market have opted various strategies such as product launches, acquisition, and investments in R&D for advancement in carrier screening to strengthen their position in the market and sustain the competitive environment.

Alarming increase in prevalence of fetal chromosomal abnormalities and genetic disorders across the globe is one of the key factors driving the growth of the market. However, dearth of highly skilled professionals restricts the market growth. Conversely, various technological advancements such as the development of next-generation sequencing (NGS) techniques for genetic disease screening and DNA sequencing are expected to provide lucrative opportunities for the growth of the market in near future. Extensive R&D activities in the field of biotechnology and bioinformatics along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market.

The growth of the global carrier screening market is segmented into type, technology, end user, and region. By type, the market is classified into expanded carrier screening and targeted disease carrier screening. The expanded carrier screening segment is further dived into customized panel testing and predesigned panel testing. On the basis of technology, the market is categorized into DNA sequencing, polymerase chain reaction, microarrays, and other technologies. The end users covered in the study include hospitals & clinics, reference laboratories, physician offices, and others. Region wise, the market is thoroughly analyzed across North America, Europe, Asia-Pacific, and LAMEA.

This report provides comprehensive competitive analysis and profiles of prominent market players such as Eurofins Scientific, Invitae Corporation, Opko Health, Fulgent Genetics Inc., Quest Diagnostics Incorporated, Natera Inc. Myriad Genetics, Illumina Inc., Thermo Fisher Scientific Inc., and Luminex Corporation.

KEY BENEFITS FOR STAKEHOLDERS


  • The study provides an in-depth analysis of the global carrier screening market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the products and end users of carrier screening used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS


By Type

  • Expanded Carrier Screening
  • Customized Panel Testing
  • Predesigned Panel Testing
  • Targeted Disease Carrier Screening

By Technology

  • DNA Sequencing
  • Polymerase Chain Reaction
  • Microarrays
  • Other Technologies

By End User

  • Hospitals & Clinics
  • Reference Laboratories
  • Physician Offices

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Spain
  • Italy
  • UK
  • Rest of Europe
  • Asia-Pacific
  • Australia
  • Japan
  • India
  • China
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • Eurofins Scientific
  • Invitae Corporation
  • Opko Health
  • Fulgent Genetics Inc.
  • Quest Diagnostics Incorporated
  • Natera Inc.
  • Myriad Genetics
  • Illumina Inc.
  • Thermo Fisher Scientific Inc.
  • Luminex Corporation
Frequently Asked Questions about the Carrier Screening Market

What is the estimated value of the Carrier Screening Market?

The Carrier Screening Market was estimated to be valued at $1378.1 million in 2020.

What is the growth rate of the Carrier Screening Market?

The growth rate of the Carrier Screening Market is 11.3%, with an estimated value of $4002.1 million by 2030.

What is the forecasted size of the Carrier Screening Market?

The Carrier Screening Market is estimated to be worth $4002.1 million by 2030.

Who are the key companies in the Carrier Screening Market?

Key companies in the Carrier Screening Market include Eurofins Scientific, Invitae Corporation, Opko Health, Fulgent Genetics Inc., Quest Diagnostics Incorporated, Natera Inc. Myriad Genetics, Illumina Inc. and Luminex Corporation.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Eurofins Scientific
  • Fulgent Genetics Inc.
  • Illumina Inc.
  • Invitae Corporation
  • Luminex Corporation
  • Opko Health
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective

CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increasing prevalence of fetal chromosomal abnormalities and genetic disorders
3.5.1.2. Initiatives and Funding from Government & Private Bodies for Large-Scale Carrier Screening & Sequencing Projects
3.5.2. Restraints
3.5.2.1. Dearth of skilled professionals
3.5.3. Opportunities
3.5.3.1. R&D investment by pharmaceutical
3.6. Covid-19 Impact analysis on the carrier screening market

CHAPTER 4: CARRIER SCREENING MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast, by type
4.2. Expanded Carrier Screening
4.2.1. Key trends and growth opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.2.4. Market size and forecast, by type
4.2.4.1. Customized Panel Testing
4.2.4.2. Predesigned Panel Testing
4.3. Targeted Disease Carrier Screening
4.3.1. Key trends and growth opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

CHAPTER 5: CARRIER SCREENING MARKET, BY TECHNOLOGY
5.1. Overview
5.1.1. Market size and forecast, by technology
5.2. DNA Sequencing
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Polymerase Chain Reaction
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Microarrays
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Others
5.5.1. Market size and forecast
5.5.2. Market analysis, by country

CHAPTER 6: CARRIER SCREENING MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast, by technology
6.2. Hospitals & clinics
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Reference Laboratories
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Physician Offices
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Others
6.5.1. Market size and forecast
6.5.2. Market analysis, by country

CHAPTER 7: CARRIER SCREENING MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast, by region
7.2. North America
7.2.1. Key trends and growth opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by technology
7.2.4. Market size and forecast, by end user
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.2. U.S. market size and forecast, by Type
7.2.5.3. U.S. market size and forecast, by technology
7.2.5.4. U.S. market size and forecast, by end user
7.2.5.5. Canada
7.2.5.6. Canada market size and forecast, by Type
7.2.5.7. Canada market size and forecast, by technology
7.2.5.8. Canada market size and forecast, by end user
7.2.5.9. Mexico
7.2.5.10. Mexico market size and forecast, by Type
7.2.5.11. Mexico market size and forecast, by technology
7.2.5.12. Mexico market size and forecast, by end user
7.3. Europe
7.3.1. Key trends and growth opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by technology
7.3.4. Market size and forecast, by end user
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.2. Germany market size and forecast, by Type
7.3.5.3. Germany market size and forecast, by technology
7.3.5.4. Germany market size and forecast, by end user
7.3.5.5. France
7.3.5.6. France market size and forecast, by Type
7.3.5.7. France market size and forecast, by technology
7.3.5.8. France market size and forecast, by end user
7.3.5.9. UK
7.3.5.10. UK market size and forecast, by Type
7.3.5.11. UK market size and forecast, by technology
7.3.5.12. UK market size and forecast, by end user
7.3.5.13. Italy
7.3.5.14. Italy market size and forecast, by Type
7.3.5.15. Italy market size and forecast, by technology
7.3.5.16. Italy market size and forecast, by end user
7.3.5.17. Spain
7.3.5.18. Spain market size and forecast, by Type
7.3.5.19. Spain market size and forecast, by technology
7.3.5.20. Spain market size and forecast, by end user
7.3.5.21. Rest of Europe
7.3.5.22. Rest of Europe market size and forecast, by Type
7.3.5.23. Rest of Europe market size and forecast, by technology
7.3.5.24. Rest of Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key trends and growth opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by technology
7.4.4. Market size and forecast, by end user
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.2. Japan market size and forecast, by Type
7.4.5.3. Japan market size and forecast, by technology
7.4.5.4. Japan market size and forecast, by end user
7.4.5.5. China
7.4.5.6. China market size and forecast, by Type
7.4.5.7. China market size and forecast, by technology
7.4.5.8. China market size and forecast, by end user
7.4.5.9. India
7.4.5.10. India market size and forecast, by Type
7.4.5.11. India market size and forecast, by technology
7.4.5.12. India market size and forecast, by end user
7.4.5.13. Australia
7.4.5.14. Australia market size and forecast, by Type
7.4.5.15. Australia market size and forecast, by technology
7.4.5.16. Australia market size and forecast, by end user
7.4.5.17. South Korea
7.4.5.18. South Korea market size and forecast, by Type
7.4.5.19. South Korea market size and forecast, by technology
7.4.5.20. South Korea market size and forecast, by end user
7.4.5.21. Rest of Asia-Pacific
7.4.5.22. Rest of Asia-Pacific market size and forecast, by Type
7.4.5.23. Rest of Asia-Pacific market size and forecast, by technology
7.4.5.24. Rest of Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by technology
7.5.4. Market size and forecast, by end user
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.2. Brazil market size and forecast, by Type
7.5.5.3. Brazil market size and forecast, by technology
7.5.5.4. Brazil market size and forecast, by end user
7.5.5.5. Saudi Arabia
7.5.5.6. Saudi Arabia market size and forecast, by Type
7.5.5.7. Saudi Arabia market size and forecast, by technology
7.5.5.8. Saudi Arabia market size and forecast, by end user
7.5.5.9. South Africa
7.5.5.10. South Africa market size and forecast, by Type
7.5.5.11. South Africa market size and forecast, by technology
7.5.5.12. South Africa market size and forecast, by end user
7.5.5.13. Rest of LAMEA
7.5.5.14. Rest of LAMEA market size and forecast, by Type
7.5.5.15. Rest of LAMEA market size and forecast, by technology
7.5.5.16. Rest of LAMEA market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES
8.1. EUROFINS SCIENTIFIC
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Product portfolio
8.1.4. Business performance
8.2. FULGENT GENETICS INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. Invitae Corporation
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. Illumina, Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. LUMINEX CORPORATION
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. MYRIAD GENETICS INC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. NATERA INC.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
Source: Corporate Publications and AMR Analysis
Source: Corporate Publications and AMR Analysis
8.7.6. Key strategic moves and developments
8.8. Opko Health
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. QUEST DIAGNOSTICS INCORPORATED
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. THERMO FISHER SCIENTIFIC, INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments

List of Tables
TABLE 01. CARRIER SCREENING MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 02. CARRIER SCREENING MARKET FOR DRUG THERAPY, BY REGION, 2020-2030($MILLION)
TABLE 03. EXPANDED CARRIER SCREENING CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 04. CARRIER SCREENING MARKET FOR TARGETED CARRIER SCREENING, BY REGION, 2020-2030 ($MILLION)
TABLE 05. CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 06. CARRIER SCREENING MARKET FOR DNA SEQUENCING, BY REGION, 2020-2030($MILLION)
TABLE 07. CARRIER SCREENING MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2020-2030 ($MILLION)
TABLE 08. CARRIER SCREENING MARKET FOR MICROARRAYS, BY REGION, 2020-2030 ($MILLION)
TABLE 09. CARRIER SCREENING MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 10. CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 11. CARRIER SCREENING MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020-2030($MILLION)
TABLE 12. CARRIER SCREENING MARKET FOR REFERENCE LABORATORIES, BY REGION, 2020-2030 ($MILLION)
TABLE 13. CARRIER SCREENING MARKET FOR PHYSICIAN OFFICES, BY REGION, 2020-2030 ($MILLION)
TABLE 14. CARRIER SCREENING MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 15. CARRIER SCREENING MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 16. NORTH AMERICA CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 17. NORTH AMERICA CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 18. NORTH AMERICA CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 19. NORTH AMERICA CARRIER SCREENING MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 20. U.S. CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 21. U.S. CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 22. U.S. CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 23. CANADA CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 24. CANADA CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 25. CANADA CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 26. MEXICO CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 27. MEXICO CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 28. MEXICO CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 29. EUROPE CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 30. EUROPE CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 31. EUROPE CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 32. EUROPE CARRIER SCREENING MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 33. GERMANY CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 34. GERMANY CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 35. GERMANY CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 36. FRANCE CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 37. FRANCE CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 38. FRANCE CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 39. UK CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 40. UK CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 41. UK CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 42. ITALY CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 43. ITALY CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 44. ITALY CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 45. SPAIN CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 46. SPAIN CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 47. SPAIN CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 48. REST OF EUROPE CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 49. REST OF EUROPE CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 50. REST OF EUROPE CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 51. ASIA-PACIFIC CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 52. ASIA-PACIFIC CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 53. ASIA-PACIFIC CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 54. ASIA-PACIFIC CARRIER SCREENING MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 55. JAPAN CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 56. JAPAN CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 57. JAPAN CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 58. CHINA CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 59. CHINA CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 60. CHINA CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 61. INDIA CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 62. INDIA CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 63. INDIA CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 64. AUSTRALIA CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 65. AUSTRALIA CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 66. AUSTRALIA CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 67. SOUTH KOREA CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 68. SOUTH KOREA CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 69. SOUTH KOREA CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 73. LAMEA CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 74. LAMEA CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 75. LAMEA CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 76. LAMEA CARRIER SCREENING MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 77. BRAZIL CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 78. BRAZIL CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 79. BRAZIL CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 80. SAUDI ARABIA CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 81. SAUDI ARABIA CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 82. SAUDI ARABIA CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 83. SOUTH AFRICA CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 84. SOUTH AFRICA CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 85. SOUTH AFRICA CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 86. REST OF LAMEA CARRIER SCREENING MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 87. REST OF LAMEA CARRIER SCREENING MARKET, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 88. REST OF LAMEA CARRIER SCREENING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 89. EUROFINS: COMPANY SNAPSHOT
TABLE 90. EUROFINS: PRODUCT PORTFOLIO
TABLE 91. FULGENT: COMPANY SNAPSHOT
TABLE 92. FULGENT: OPERATING SEGMENTS
TABLE 93. FULGENT: PRODUCT PORTFOLIO
TABLE 94. FULGENT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 95. INVITAE: COMPANY SNAPSHOT
TABLE 96. INVITAE: OPERATING SEGMENTS
TABLE 97. INVITAE: PRODUCT PORTFOLIO
TABLE 98. ILLUMINA: COMPANY SNAPSHOT
TABLE 99. ILLUMINA: OPERATING SEGMENTS
TABLE 100. ILLUMINA: PRODUCT PORTFOLIO
TABLE 101. LUMINEX: COMPANY SNAPSHOT
TABLE 102. LUMINEX: OPERATING SEGMENTS
TABLE 103. LUMINEX: PRODUCT PORTFOLIO
TABLE 104. MYRIAD: COMPANY SNAPSHOT
TABLE 105. MYRIAD: OPERATING SEGMENTS
TABLE 106. MYRIAD: PRODUCT PORTFOLIO
TABLE 107. MYRIAD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 108. NATERA: COMPANY SNAPSHOT
TABLE 109. NATERA: OPERATING SEGMENTS
TABLE 110. NATERA: PRODUCT PORTFOLIO
TABLE 111. OPKO: COMPANY SNAPSHOT
TABLE 112. OPKO: PRODUCT PORTFOLIO
TABLE 113. QUEST DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 114. QUEST DIAGNOSTICS: OPERATING SEGMENTS
TABLE 115. QUEST DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 116. QUEST DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 117. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 118. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 119. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO

List of Figures
FIGURE 01. TOP INVESTMENT POCKETS
FIGURE 02. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 03. MODERATE BARGAINING POWER OF BUYERS
FIGURE 04. MODERATE THREAT OF SUBSTITUTES
FIGURE 05. MODERATE THREAT OF NEW ENTRANTS
FIGURE 06. HIGH INTENSITY OF RIVALRY
FIGURE 07. TOP PLAYER POSITIONING, 2020
FIGURE 08. COMPARATIVE SHARE ANALYSIS OF CARRIER SCREENING MARKET FOR EXPANDED CARRIER SCREENING BY COUNTRY, 2020 & 2030 (%)
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF CARRIER SCREENING MARKET FOR TARGETED CARRIER SCREENING BY COUNTRY, 2020 & 2030 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF CARRIER SCREENING MARKET FOR DNA SEQUENCING BY COUNTRY, 2020 & 2030 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF CARRIER SCREENING MARKET FOR POLYMERASE CHAIN REACTION BY COUNTRY, 2020 & 2030 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CARRIER SCREENING MARKET FOR MICROARRAYS BY COUNTRY, 2020 & 2030 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF CARRIER SCREENING MARKET FOR OTHERS BY COUNTRY, 2020 & 2030 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF CARRIER SCREENING MARKET FOR HOSPITALS & CLINICS BY COUNTRY, 2020 & 2030 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CARRIER SCREENING MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2020 & 2030 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CARRIER SCREENING MARKET FOR PHYSICIAN OFFICES BY COUNTRY, 2020 & 2030 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CARRIER SCREENING MARKET FOR OTHERS BY COUNTRY, 2020 & 2030 (%)
FIGURE 18. EUROFINS: NET SALES, 2018-2020 ($MILLION)
FIGURE 19. EUROFINS REVENUE SHARE BY REGION, 2020 (%)
FIGURE 20. FULGENT: NET SALES, 2018-2020 ($MILLION)
FIGURE 21. FULGENT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 22. FULGENT: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 23. INVITAE: NET SALES, 2018-2020 ($MILLION)
FIGURE 24. INVITAE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 25. INVITAE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 26. ILLUMINA: NET SALES, 2018-2020 ($MILLION)
FIGURE 27. ILLUMINA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 28. ILLUMINA: REVENUE SHARE BY GEOGRAPHY, 2020 (%)
FIGURE 29. LUMINEX: NET SALES, 2018-2020 ($MILLION)
FIGURE 30. LUMINEX: REVENUE SHARE BY SEGMENT, 2020(%)
FIGURE 31. LUMINEX: REVENUE SHARE BY REGION, 2020(%)
FIGURE 32. MYRIAD: NET SALES, 2018-2020 ($MILLION)
FIGURE 33. MYRIAD: REVENUE SHARE BY SEGMENT, 2020(%)
FIGURE 34. NATERA: NET SALES, 2018-2020 ($MILLION)
FIGURE 35. NATERA: REVENUE SHARE BY SEGMENT, 2020(%)
FIGURE 36. NATERA: REVENUE SHARE BY REGION, 2020(%)
FIGURE 37. OPKO: NET SALES, 2018-2020 ($MILLION)
FIGURE 38. QUEST DIAGNOSTICS: NET SALES, 2018-2020 ($MILLION)
FIGURE 39. QUEST DIAGNOSTICS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 40. THERMO FISHER SCIENTIFIC: REVENUE, 2018-2020 ($MILLION)
FIGURE 41. THERMO FISHER SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 42. THERMO FISHER SCIENTIFIC: REVENUE SHARE BY GEOGRAPHY, 2020 (%)
Note: Product cover images may vary from those shown
  • Eurofins Scientific
  • Invitae Corporation
  • Opko Health
  • Fulgent Genetics Inc.
  • Quest Diagnostics Incorporated
  • Natera Inc. Myriad Genetics
  • Illumina Inc.
  • Thermo Fisher Scientific Inc.
  • Luminex Corporation
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...